Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

News Conference News ESC 2016

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Michael O'Riordan

August 28, 2016

News Conference News ACC 2016

Cardioband Transcatheter Mitral Annulus Repair Appears Safe, Effective in Functional MR

Shelley Wood

April 07, 2016

News Conference News ACC 2016

Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI

Yael L. Maxwell

April 04, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Daily News

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Shelley Wood

January 21, 2016

News Industry News

Scripps experts present at 2015 TCT scientific symposium

October 09, 2015

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

‘Urgent’ Stenting or Surgery Safe After Thrombolysis for Stroke

Jason Kahn

February 27, 2014

News Daily News

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

December 08, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Plavix and PPI

June 28, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News TCT 2012

No Excess Bleeding with EES vs. BMS in Octogenarians Despite Prolonged DAPT

October 26, 2012

News Daily News

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Caitlin E. Cox

October 04, 2012

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Cardioband Transcatheter Mitral Annulus Repair Appears Safe, Effective in Functional MR

Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Scripps experts present at 2015 TCT scientific symposium

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

‘Urgent’ Stenting or Surgery Safe After Thrombolysis for Stroke

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

Conversations in Cardiology: Plavix and PPI

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

No Excess Bleeding with EES vs. BMS in Octogenarians Despite Prolonged DAPT

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content